ASCO: In early study results, Grail's blood test identifies 12 cancers before they spread

June 3, 2019

According to the research conferences of ASCO, Grail can now identify genetic markers for twelve different cancers.  Maryland Oncology Hematology research participates in this Grail study, with our patients contributing to this new cutting edge research to benefit future people at risk for cancer.  Read more at the lnik:

Annual Report to the Nation: Overall cancer mortality continues to decline

May 31, 2019

Check out this annual report from the NIH for this year's cancer related statistics. New trends in cancer demographics show an over decline in Cancer Mortality as well as differences in mortality in men and women.  Read more here:

Five key takeaways from ASCO, the world's largest cancer research conference

June 4, 2018

ASCO is one of the largest research confrences, providing a platform for biotech companies to present results of cancer research.  This conference attracts thousands with interest in cancer research, displaying results that are practice-changing for doctors, life-changing for patients, and market-moving for investors. Read more about the large economic and treatment affects of this conference at the link:

Blood test offers hope of finding cancers before symptoms develop

June 1, 2018 

Maryland Oncology and Hematology is participating in this study, giving the opportunity to our patients to contribute to cutting edge research of the future.  According to this article, large advancements in detecting cancer based on blood tests is currently under way.  Read more at the link: